8-KLeadership ChangesExhibits & Filings

CME GROUP INC. 8-K Report, Executive Changes (Apr 24, 2012)

Filed April 24, 2012For Securities:CME

Summary

This 8-K filing from CME Group Inc. (CME) on April 24, 2012, primarily reports on significant changes in executive leadership and their revised employment agreements. The company announced the upcoming retirement of its President, Craig S. Donohue, and the planned succession of Terrence A. Duffy to Executive Chairman and President, and Phupinder S. Gill to Chief Executive Officer. These leadership transitions are set to occur no later than December 31, 2012. The filing details the revised employment agreements for both Mr. Duffy and Mr. Gill, outlining their new base salaries, bonus and equity incentive plan participation, and severance packages. These agreements also include provisions related to change of control, death, disability, and non-compete clauses, aiming to provide stability and incentivize continued performance during and after these leadership changes. Investors should note the increased base salaries and the comprehensive severance and equity vesting terms, which reflect the importance of retaining key leadership during this strategic transition.

Key Highlights

  • 1CME Group Inc. announced leadership transitions with President Craig S. Donohue set to retire by December 31, 2012.
  • 2Terrence A. Duffy will transition from Executive Chairman to Executive Chairman and President.
  • 3Phupinder S. Gill, currently President, will assume the role of Chief Executive Officer.
  • 4Revised employment agreements were entered into with Terrence A. Duffy and Phupinder S. Gill, effective April 18, 2012.
  • 5Mr. Duffy's base salary will increase to $1,250,000 annually from the Transition Date, and Mr. Gill's will increase to $1,000,000 annually.
  • 6Both executives have revised severance packages that include lump-sum payments and accelerated vesting of equity awards upon termination without cause, change of control, death, or disability.
  • 7The agreements include non-compete clauses for a period of one year post-employment, restricting engagement with competing derivatives exchanges or clearing services and soliciting employees.

Frequently Asked Questions